3q29 microdeletion syndrome
A genetic disorder caused by a deletion on chromosome 3
| 3q29 microdeletion syndrome | |
|---|---|
| |
| Synonyms | |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Developmental delay, intellectual disability, autism spectrum disorder, anxiety, schizophrenia |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Genetic testing, chromosomal microarray analysis |
| Differential diagnosis | |
| Prevention | |
| Treatment | Supportive care, special education, behavioral therapy |
| Medication | |
| Prognosis | Variable |
| Frequency | 1 in 30,000 to 1 in 40,000 |
| Deaths | |
3q29 microdeletion syndrome is a rare genetic disorder characterized by a deletion of a small segment of chromosome 3 at the q29 band. This condition can lead to a variety of developmental and health issues, including intellectual disability, developmental delay, and distinctive facial features.
Genetics[edit]
The 3q29 microdeletion syndrome is caused by the deletion of a segment of DNA on the long arm (q arm) of chromosome 3. This deletion typically spans approximately 1.6 million base pairs and affects multiple genes. The deletion is usually de novo, meaning it occurs as a new mutation in the affected individual and is not inherited from the parents.
Clinical Features[edit]
Individuals with 3q29 microdeletion syndrome may present with a range of clinical features, which can vary in severity. Common features include:
- Intellectual disability
- Developmental delay
- Autism spectrum disorder
- Microcephaly (small head size)
- Distinctive facial features such as a long face, high nasal bridge, and prominent ears
- Congenital heart defects
- Gastrointestinal issues
Diagnosis[edit]
Diagnosis of 3q29 microdeletion syndrome is typically made using chromosomal microarray analysis, which can detect the deletion of the 3q29 region. Karyotyping may also be used, but it is less sensitive for detecting small deletions.
Management[edit]
There is no cure for 3q29 microdeletion syndrome, and management focuses on addressing the specific symptoms and needs of the individual. This may include:
- Early intervention programs for developmental delays
- Special education services
- Behavioral therapy for autism spectrum disorder
- Regular monitoring and treatment of associated health issues
Prognosis[edit]
The prognosis for individuals with 3q29 microdeletion syndrome varies depending on the severity of symptoms and the presence of associated health conditions. With appropriate support and interventions, many individuals can lead fulfilling lives.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

